Drug Patent Expirations in November 2014

Drug Patent Expirations for November 2014

Tradename Applicant Generic Name Patent Number Patent Expiration
ATROVENT HFA Boehringer Ingelheim ipratropium bromide 5,683,677 Nov 4, 2014
PALLADONE Purdue Pharma Lp hydromorphone hydrochloride 6,335,033 Nov 4, 2014
QVAR 80 Teva Branded Pharm beclomethasone dipropionate 5,683,677 Nov 4, 2014
PALLADONE Purdue Pharma Lp hydromorphone hydrochloride 5,958,452 Nov 4, 2014
ZETONNA Takeda Gmbh ciclesonide 5,683,677 Nov 4, 2014
ALVESCO Takeda Gmbh ciclesonide 5,683,677 Nov 4, 2014
PALLADONE Purdue Pharma Lp hydromorphone hydrochloride 5,965,161 Nov 4, 2014
QVAR 40 Teva Branded Pharm beclomethasone dipropionate 5,683,677 Nov 4, 2014
PALLADONE Purdue Pharma Lp hydromorphone hydrochloride 6,706,281 Nov 4, 2014
QNASL Teva Branded Pharm beclomethasone dipropionate 5,683,677 Nov 4, 2014
PALLADONE Purdue Pharma Lp hydromorphone hydrochloride 6,743,442 Nov 4, 2014
NOVOLOG PENFILL Novo Nordisk Inc insulin aspart recombinant 5,626,566*PED Nov 6, 2014
APTIVUS Boehringer Ingelheim tipranavir 6,169,181*PED Nov 6, 2014
INTEGRILIN Schering eptifibatide 5,686,570 Nov 11, 2014
INTEGRILIN Schering eptifibatide 5,756,451 Nov 11, 2014
DICLOFENAC SODIUM Falcon Pharms diclofenac sodium 5,653,972 Nov 16, 2014
DICLOFENAC SODIUM Falcon Pharms diclofenac sodium 5,603,929 Nov 16, 2014
FOSAMAX Merck alendronate sodium 5,462,932*PED Nov 17, 2014
SURFAXIN Discovery Labs lucinactant 5,407,914 Nov 17, 2014
FUZEON Roche enfuvirtide 6,133,418 Nov 17, 2014
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION Sanofi Aventis Us fexofenadine hydrochloride; pseudoephedrine hydrochloride 7,135,571*PED Nov 18, 2014
CHILDREN’S ALLEGRA HIVES Sanofi Aventis Us fexofenadine hydrochloride 7,135,571*PED Nov 18, 2014
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION Sanofi Aventis Us fexofenadine hydrochloride; pseudoephedrine hydrochloride 7,138,524*PED Nov 18, 2014
CELLCEPT Roche Palo mycophenolate mofetil 5,688,529 Nov 18, 2014
ALLEGRA ALLERGY Sanofi Aventis Us fexofenadine hydrochloride 7,135,571*PED Nov 18, 2014
ALLEGRA Sanofi Aventis Us fexofenadine hydrochloride 7,135,571*PED Nov 18, 2014
CHILDREN’S ALLEGRA HIVES Sanofi Aventis Us fexofenadine hydrochloride 7,138,524*PED Nov 18, 2014
ALLEGRA HIVES Sanofi Aventis Us fexofenadine hydrochloride 7,135,571*PED Nov 18, 2014
CHILDREN’S ALLEGRA ALLERGY Sanofi Aventis Us fexofenadine hydrochloride 7,135,571*PED Nov 18, 2014
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION Sanofi Aventis Us fexofenadine hydrochloride; pseudoephedrine hydrochloride 7,138,524*PED Nov 18, 2014
CHILDREN’S ALLEGRA ALLERGY Sanofi Aventis Us fexofenadine hydrochloride 7,138,524*PED Nov 18, 2014
ALLEGRA ALLERGY Sanofi Aventis Us fexofenadine hydrochloride 7,138,524*PED Nov 18, 2014
ALLEGRA Sanofi Aventis Us fexofenadine hydrochloride 7,138,524*PED Nov 18, 2014
ALLEGRA HIVES Sanofi Aventis Us fexofenadine hydrochloride 7,138,524*PED Nov 18, 2014
PRILOSEC Astrazeneca omeprazole magnesium 5,690,960 Nov 25, 2014
VELTIN Stiefel Gsk clindamycin phosphate; tretinoin 5,690,923 Nov 25, 2014
PRILOSEC OTC Astrazeneca omeprazole magnesium 5,690,960 Nov 25, 2014
NEXIUM 24HR Astrazeneca Lp esomeprazole magnesium 5,690,960 Nov 25, 2014
NEXIUM IV Astrazeneca esomeprazole sodium 5,877,192*PED Nov 27, 2014
NEXIUM Astrazeneca esomeprazole magnesium 6,875,872*PED Nov 27, 2014
VIMOVO Horizon Pharma esomeprazole magnesium; naproxen 6,875,872*PED Nov 27, 2014
NEXIUM Astrazeneca esomeprazole magnesium 5,877,192*PED Nov 27, 2014
SULAR Shionogi Inc nisoldipine 5,626,874 Nov 30, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2014 Biotechblog

Comments are closed.

%d bloggers like this: